
### [NCIT:C8771](http://purl.obolibrary.org/obo/NCIT_C8771)
**Label:** Stage IV Pharyngeal Cancer

**Subclasses:** [NCIT:C8229](http://purl.obolibrary.org/obo/NCIT_C8229) (Stage IV Nasopharyngeal Undifferentiated Carcinoma AJCC v7), [NCIT:C132820](http://purl.obolibrary.org/obo/NCIT_C132820) (Stage IV Nasopharyngeal Carcinoma AJCC v8), [NCIT:C9218](http://purl.obolibrary.org/obo/NCIT_C9218) (Stage IV Oropharyngeal Carcinoma AJCC v6), [NCIT:C8228](http://purl.obolibrary.org/obo/NCIT_C8228) (Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7), [NCIT:C8533](http://purl.obolibrary.org/obo/NCIT_C8533) (Stage IV Hypopharyngeal Carcinoma AJCC v6), [NCIT:C115089](http://purl.obolibrary.org/obo/NCIT_C115089) (Stage IV Oropharyngeal Undifferentiated Carcinoma AJCC v7), [NCIT:C8235](http://purl.obolibrary.org/obo/NCIT_C8235) (Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7), [NCIT:C7397](http://purl.obolibrary.org/obo/NCIT_C7397) (Stage IV Nasopharyngeal Carcinoma AJCC v6), [NCIT:C8220](http://purl.obolibrary.org/obo/NCIT_C8220) (Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7), [NCIT:C89047](http://purl.obolibrary.org/obo/NCIT_C89047) (Stage IV Hypopharyngeal Carcinoma AJCC v7), [NCIT:C88984](http://purl.obolibrary.org/obo/NCIT_C88984) (Stage IV Nasopharyngeal Carcinoma AJCC v7), [NCIT:C133008](http://purl.obolibrary.org/obo/NCIT_C133008) (Stage IV Hypopharyngeal Carcinoma AJCC v8), [NCIT:C89023](http://purl.obolibrary.org/obo/NCIT_C89023) (Stage IV Oropharyngeal Carcinoma AJCC v7), 

**Class expressions from DL-Learner:**

- [NCIT:C27971](http://purl.obolibrary.org/obo/NCIT_C27971) (Stage IV) 53.57%
- Thing 53.00%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40308](http://purl.obolibrary.org/obo/NCIT_C40308) (Vulvar Apocrine Adenocarcinoma))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40307](http://purl.obolibrary.org/obo/NCIT_C40307) (Vulvar Clear Cell Hidradenocarcinoma))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40306](http://purl.obolibrary.org/obo/NCIT_C40306) (Vulvar Eccrine Porocarcinoma))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40301](http://purl.obolibrary.org/obo/NCIT_C40301) (Adenoma of Minor Vestibular Glands))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40299](http://purl.obolibrary.org/obo/NCIT_C40299) (Bartholin Gland Adenoma))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40298](http://purl.obolibrary.org/obo/NCIT_C40298) (Bartholin Gland Small Cell Carcinoma))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40297](http://purl.obolibrary.org/obo/NCIT_C40297) (Bartholin Gland Transitional Cell Carcinoma))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40296](http://purl.obolibrary.org/obo/NCIT_C40296) (Bartholin Gland Adenosquamous Carcinoma))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40295](http://purl.obolibrary.org/obo/NCIT_C40295) (Bartholin Gland Adenoid Cystic Carcinoma))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40293](http://purl.obolibrary.org/obo/NCIT_C40293) (Bartholin Gland Squamous Cell Carcinoma))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40290](http://purl.obolibrary.org/obo/NCIT_C40290) (Vestibular Micropapillomatosis))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40287](http://purl.obolibrary.org/obo/NCIT_C40287) (Vulvar Warty Carcinoma))) 38.93%


